These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 39057409)
1. Laura M; Marzia V; Donatella D; Lorenzo DCM; Carla G; Antiga E; Alice V; Marzia C; Emanuela B Mar Drugs; 2024 Jun; 22(7):. PubMed ID: 39057409 [TBL] [Abstract][Full Text] [Related]
2. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation. Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123 [TBL] [Abstract][Full Text] [Related]
3. Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate. Rai VK; Sinha P; Yadav KS; Shukla A; Saxena A; Bawankule DU; Tandon S; Khan F; Chanotiya CS; Yadav NP J Ethnopharmacol; 2020 Oct; 261():113127. PubMed ID: 32623016 [TBL] [Abstract][Full Text] [Related]
4. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice. Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073 [TBL] [Abstract][Full Text] [Related]
5. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway. Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Emami Z; Shobeiri SS; Khorrami R; Haghnavaz N; Rezaee MA; Moghadam M; Pordel S; Sankian M Mediators Inflamm; 2024; 2024():5821996. PubMed ID: 39045230 [TBL] [Abstract][Full Text] [Related]
7. Topical anti-TNF-a ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB/c mice. Shobeiri SS; Dashti M; Pordel S; Rezaee M; Haghnavaz N; Moghadam M; Ansari B; Sankian M Cytokine; 2023 Dec; 172():156406. PubMed ID: 37879125 [TBL] [Abstract][Full Text] [Related]
8. Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689 [TBL] [Abstract][Full Text] [Related]
9. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways. Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629 [TBL] [Abstract][Full Text] [Related]
10. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments. Smajlović A; Haverić A; Alić A; Hadžić M; Smajlović A; Mujezinović I; Lojo-Kadrić N; Ramić J; Elez-Burnjaković N; Haverić S; Pojskić L Mol Biol Rep; 2021 May; 48(5):4295-4303. PubMed ID: 34097205 [TBL] [Abstract][Full Text] [Related]
11. Unlocking milk thistle's anti-psoriatic potential in mice: Targeting PI3K/AKT/mTOR and KEAP1/NRF2/NF-κB pathways to modulate inflammation and oxidative stress. Kamel NM; El-Sayed SS; El-Said YAM; El-Kersh DM; Hashem MM; Mohamed SS Int Immunopharmacol; 2024 Sep; 139():112781. PubMed ID: 39059101 [TBL] [Abstract][Full Text] [Related]
12. Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model. Shobeiri SS; Rezaee M; Pordel S; Haghnnavaz N; Dashti M; Moghadam M; Sankian M Int Immunopharmacol; 2022 Sep; 110():108963. PubMed ID: 35724603 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis. Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833 [TBL] [Abstract][Full Text] [Related]
14. Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice. Tawfik NF; Abdel-Rashid RS; El-Sayed EK; Abdel-Moneum R; Khattab MA; Ahmed AA; Lai KH; Hashad N; Moharram FA Int Immunopharmacol; 2024 Sep; 139():112733. PubMed ID: 39043105 [TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
16. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840 [TBL] [Abstract][Full Text] [Related]
17. Thymol activates TRPM8-mediated Ca Wang W; Wang H; Zhao Z; Huang X; Xiong H; Mei Z Toxicol Appl Pharmacol; 2020 Nov; 407():115247. PubMed ID: 32971067 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of a methanol extract of Dictamnus dasycarpus Turcz. root bark on imiquimod-induced psoriasis. Choi M; Yi JK; Kim SY; Ryu JH; Lee J; Kwon W; Jang S; Kim D; Kim M; Kim H; Kim SH; Choi SK; Ryoo ZY BMC Complement Altern Med; 2019 Dec; 19(1):347. PubMed ID: 31791315 [TBL] [Abstract][Full Text] [Related]
19. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice. Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice. Deng G; Chen W; Wang P; Zhan T; Zheng W; Gu Z; Wang X; Ji X; Sun Y Int Immunopharmacol; 2019 Sep; 74():105682. PubMed ID: 31203155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]